Revelation Capital Management as of Dec. 31, 2021
Portfolio Holdings for Revelation Capital Management
Revelation Capital Management holds 6 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Singular Genomics Systems In | 58.2 | $60M | 5.2M | 11.56 | |
| 23andme Holding Class A Com | 30.0 | $31M | 4.7M | 6.66 | |
| Neuropace (NPCE) | 6.5 | $6.7M | 667k | 10.08 | |
| Somalogic Class A Com | 4.2 | $4.3M | 371k | 11.64 | |
| Natera (NTRA) | 0.7 | $739k | 7.9k | 93.27 | |
| CVRX (CVRX) | 0.5 | $467k | 38k | 12.23 |
